This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Some passages on what makes a job “good” from The Happiness Hypothesis by Jonathan Haidt: Psychologists have referred to this basic need as a need for competence, industry, or mastery. [Psychologist Robert] White called it the “effectance motive,” which he defined as the need or drive to develop competence through interacting with and controlling one’s environment.
Nuclidium has begun a phase I clinical trial evaluating the use of copper-61 (Cu-61) in patients with prostate-specific membrane antigen (PSMA)-positive prostate cancer. The radiopharmaceutical is called Cu-61 NuriPro and is part of the company's NuriPro program, it said. The trial is being conducted at Hoag Memorial Hospital Presbyterian in Newport Beach, CA, and will evaluate the safety and effectiveness of Cu-61 NuriPro for imaging prostate cancer compared to an F-18 FDG-based PSMA-targeting
Offering standardized assessment of amyloid plaque and insights on tau protein tangles, the newly clearly FDA features of Centiloid scoring and tau PET quantification with syngo.PET Cortical Analysis software may facilitate diagnosis of Alzheimer’s disease.
Smith+Nephew has entered into a co-marketing agreement with JointVue for its patented OrthoSonic 3D Surgery Planning Technology, which is the only ultrasound device available on the market for 3D preoperative planning.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
The technology industry has grown immensely over the past decade and will continue to skyrocket in the coming years. The latest advances and innovations drive this evolution, presenting many unique opportunities for established companies and up-and-coming startups. One area that has brought the tech industry opportunities and challenges is globalization.
The aim of this study was to assess recent US medical school trends in compensation for academic interventional radiologists (IR) and compensation characteristics based on rank, sex and race/ethnicity.
Publication date: Available online 19 October 2024 Source: Clinical Radiology Author(s): Navanith Murali, Lukschana Senathirajah, Matthew Taylor, James Lynch, Kelvin Tan, Tariq Ali
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content